Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance

BACKGROUND: Eculizumab has been available for the treatment of atypical hemolytic–uremic syndrome (aHUS) in Japan since 2013. To assess safety and effectiveness of eculizumab in adult aHUS patients in the real-life setting, we performed interim analysis of a post-marketing surveillance mandated by J...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Exp Nephrol
Asıl Yazarlar: Kato, Hideki, Miyakawa, Yoshitaka, Hidaka, Yoshihiko, Inoue, Norimitsu, Ito, Shuichi, Kagami, Shoji, Kaname, Shinya, Matsumoto, Masanori, Mizuno, Masashi, Matsuda, Takahisa, Shimono, Akihiko, Maruyama, Shoichi, Fujimura, Yoshihiro, Nangaku, Masaomi, Okada, Hirokazu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Singapore 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344388/
https://ncbi.nlm.nih.gov/pubmed/29959568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-018-1609-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller